These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32279510)
1. Sticky stuff: xerostomia in patients undergoing head and neck radiotherapy-prevalence, prevention, and palliative care. Snider JW; Paine CC Ann Palliat Med; 2020 May; 9(3):1340-1350. PubMed ID: 32279510 [TBL] [Abstract][Full Text] [Related]
2. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic]. Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J; Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445 [TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer. Lee MG; Freeman AR; Roos DE; Milner AD; Borg MF J Med Imaging Radiat Oncol; 2019 Feb; 63(1):142-150. PubMed ID: 30461207 [TBL] [Abstract][Full Text] [Related]
4. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients. de Castro G; Federico MH Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239 [TBL] [Abstract][Full Text] [Related]
5. Evidence-based organ-sparing radiotherapy in head and neck cancer. Dirix P; Nuyts S Lancet Oncol; 2010 Jan; 11(1):85-91. PubMed ID: 20129131 [TBL] [Abstract][Full Text] [Related]
6. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy. Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249 [TBL] [Abstract][Full Text] [Related]
7. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229 [TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400 [TBL] [Abstract][Full Text] [Related]
10. Management of xerostomia related to radiotherapy for head and neck cancer. Kahn ST; Johnstone PA Oncology (Williston Park); 2005 Dec; 19(14):1827-32; discussion 1832-4, 1837-9. PubMed ID: 16506635 [TBL] [Abstract][Full Text] [Related]
11. Xerostomia prevention after head and neck cancer treatment. Seikaly H Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460 [No Abstract] [Full Text] [Related]
13. Supportive care in head and neck oncology. de Castro G; Guindalini RS Curr Opin Oncol; 2010 May; 22(3):221-5. PubMed ID: 20186057 [TBL] [Abstract][Full Text] [Related]
14. Modification of the submandibular gland transfer procedure. Marzouki HZ; Elkhalidy Y; Jha N; Scrimger R; Debenham BJ; Harris JR; O'Connell DA; Seikaly H Laryngoscope; 2016 Nov; 126(11):2492-2496. PubMed ID: 27171786 [TBL] [Abstract][Full Text] [Related]
15. The role of saliva in oral health: strategies for prevention and management of xerostomia. Brosky ME J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151 [TBL] [Abstract][Full Text] [Related]
16. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia? You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study. Lakshman AR; Babu GS; Rao S J Cancer Res Ther; 2015; 11(1):229-33. PubMed ID: 25879367 [TBL] [Abstract][Full Text] [Related]
18. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer. Thorstad WL; Chao KS; Haughey B Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516 [TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results. Ghosh-Laskar S; Yathiraj PH; Dutta D; Rangarajan V; Purandare N; Gupta T; Budrukkar A; Murthy V; Kannan S; Agarwal JP Head Neck; 2016 Apr; 38 Suppl 1():E1481-7. PubMed ID: 26561342 [TBL] [Abstract][Full Text] [Related]
20. [Xerostomia caused by radiotherapy of patients with head and neck cancer]. Bentzen JK Ugeskr Laeger; 1992 Jan; 154(3):126-9. PubMed ID: 1738952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]